Are you Dr. Denardo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4501 X St
Suite 3016
Sacramento, CA 95817Phone+1 916-734-3787Fax+1 916-451-2857
Summary
- Dr. Sally Denardo, MD is a board certified nuclear medicine physician in Sacramento, California.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1969 - 1971- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1965 - 1969
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1965
Certifications & Licensure
- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
Publications & Presentations
PubMed
- 18 citationsConcepts, consequences, and implications of theranosisGerald L. DeNardo, Sally J. DeNardo
Seminars in Nuclear Medicine. 2012-05-01 - 12 citationsIn-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphoma.Allison L. Zwingenberger, Michael S. Kent, Ruiwu Liu, David L. Kukis, Erik R. Wisner
Plos One. 2012-04-24 - 9 citationsA general chemical synthesis platform for crosslinking multivalent single chain variable fragmentsJoan G. Schellinger, Avinash Kudupudi, Arutselvan Natarajan, Wenjun Du, Sally J. DeNardo
Organic & Biomolecular Chemistry. 2012-02-03
Grant Support
- Lymphoma-Specific Ligands;Pharmacokinetics, Radioimaging And TherapeuticsNational Cancer Institute2007–2009
- Lymphoma-Specific Ligands;Pharmacokinetics, Radioimaging And TherpeuticsNational Cancer Institute2005–2006
- Novel Approaches To Pretargeted RadioimmunotherapyNational Cancer Institute2004–2006
- Core--Radiopharmaceutical DevelopmentNational Cancer Institute1999–2006
- Development Of Immunoconjugate Therapy For Breast CancerNational Cancer Institute1994–1999
- Clinical Trials Of Biological Response ModifiersNational Cancer Institute1993–1994
- Core--ImmunopathologyNational Cancer Institute1991–1993
- Core--Cellular And Molecular ImmunobiologyNational Cancer Institute1991–1993
- Core--Antibody PharmacyNational Cancer Institute1991–1993
